Related Experiment Video

Updated: Jul 2, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Expression of G protein-coupled receptor kinase 4 is associated with breast cancer tumourigenesis

J Matsubayashi1, M Takanashi, K Oikawa

  • 1Department of Diagnostic Pathology, Tokyo Medical University, Tokyo, Japan.

The Journal of Pathology
|September 4, 2008
PubMed

Insights

G-protein-coupled receptor kinases (GRKs) are found in breast cancer but not normal tissue. GRK4 activation in cancer cells promotes MAPK signaling, suggesting a role in breast cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • G-protein-coupled receptor kinases (GRKs) regulate G-protein-coupled receptors (GPCRs) through phosphorylation.
  • GRKs and beta-arrestins are crucial for GPCR desensitization, endocytosis, and trafficking.
  • Aberrant signaling pathways are implicated in cancer development.

Purpose of the Study:

  • To investigate the expression and function of GRK4 isoforms in human breast cancer.
  • To determine the role of GRK4 in activating mitogen-activated protein kinase (MAPK) signaling pathways in breast cancer cells.
  • To explore the involvement of beta-arrestins in GRK4-mediated signaling.

Main Methods:

  • Analysis of GRK4 isoform expression in human breast cancer and normal epithelial tissues.
  • Overexpression of GRK4 in breast cancer cell lines.
  • Assessment of ERK 1/2 and JNK phosphorylation.
  • Suppression of beta-arrestin expression.

Main Results:

  • GRK4 isoforms were detected in human breast cancer but absent in normal epithelia.
  • GRK4 overexpression activated ERK 1/2 and JNK phosphorylation in breast cancer cells.
  • Beta-arrestin suppression reduced GRK4-stimulated ERK 1/2 and JNK phosphorylation.

Conclusions:

  • High-level GRK4 expression is specific to human breast cancer.
  • GRK4 activates MAPK signaling pathways (ERK 1/2, JNK) in breast cancer cells, potentially via beta-arrestins.
  • GRK4 may play a significant role in breast cancer carcinogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...